Oct 16, 2025 08:30AM
Oct 16, 2025 08:30AM
Sep 10, 2025 04:01PM
Sep 10, 2025 04:01PM
Jul 29, 2025 06:30AM
Jul 29, 2025 06:30AM
Jun 24, 2025 08:31AM Xenon Pharmaceuticals (XENE) Announces Appointment of Darren Cline as Chief Commercial Officer
Jun 24, 2025 08:30AM
Feb 11, 2025 04:17AM
Jan 3, 2024 04:14PM
Oct 2, 2023 02:26PM
Nov 7, 2022 08:30AM
Nov 7, 2022 08:30AM
Aug 9, 2022 04:01PM Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Aug 9, 2022 04:01PM
Jun 23, 2022 09:24AM
May 10, 2022 04:01PM
May 10, 2022 04:01PM
Mar 1, 2022 04:01PM
Mar 1, 2022 04:01PM
Jan 10, 2022 08:34AM Xenon Pharmaceuticals (XENE) Outlines 2022 Key Milestones
Jan 10, 2022 08:30AM
Jan 10, 2022 08:30AM
Oct 4, 2021 09:25AM
Nov 5, 2020 04:01PM
Nov 5, 2020 04:01PM
Jul 21, 2020 09:30AM
Sep 9, 2019 04:06PM Flexion Therapeutics (FLXN), Xenon Pharmaceuticals (XENE) Announce Flexion's Acquisition of Investigational NaV1.7 Inhibitor for Treatment of Post-Operative Pain
Sep 9, 2019 04:01PM
Sep 9, 2019 04:01PM
Sep 11, 2018 06:38AM
Sep 10, 2018 09:17PM
Sep 10, 2018 09:17PM
May 15, 2018 09:20AM
Apr 26, 2017 06:30AM Xenon Expands Ion Channel Neurology Pipeline with Acquisition of New Potassium Channel Modulator for the Treatment of Epilepsy
Mar 24, 2017 09:31AM
Jan 10, 2017 02:00PM
Jul 1, 2015 01:04PM
Jul 1, 2015 08:00AM
Jul 1, 2015 08:00AM
Apr 2, 2015 08:00AM
Apr 2, 2015 08:00AM Teva and Xenon Announce Enrollment of First Patient in a Phase 2b Study Evaluating TV-45070 for Postherpetic Neuralgia (PHN)
Apr 2, 2015 08:00AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All